Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St rises as Anthropic's IPO filing sharpens focus on AI trade
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 229.00 +4.97 (2.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $224.03 | 52 Week High | $109.10 | |||
| Open | $226.24 | 52 Week Low | $31.38 | |||
| Day High | $232.48 | P/E | N/A | |||
| Day Low | $224.10 | EPS | $-1.45 | |||
| Volume | 261,729 | |||||
